| Year |
Title |
Journal |
| 2022 |
Effects of Para-Toluenesulfonamide on Canine Melanoma Xenotransplants in a BALB/c Nude Mouse Model |
Animals 2022, 12(17), 2272 |
|
2021
|
Autophagic Activation and Decrease of Plasma Membrane
Cholesterol Contribute to Anticancer Activities in Non-Small Cell Lung Cancer
|
Molecules. 2021 Oct 1;26(19):5967
|
| 2018 |
Effects of para-toluenesulfonamide intratumoral injection on pulmonary adenoid cystic carcinoma complicating with severe central airway obstruction: a 5-year follow-up study
|
J Thorac Dis. 2018 Apr;10(4):2448-2455. |
| 2018 |
Para-Toluenesulfonamide Induces Anti-tumor Activity Through Akt-Dependent and –Independent mTOR/p70S6K Pathway: Roles of Lipid Raft and Cholesterol Contents
|
Front Pharmacol. 2018 Nov 13;9:1223. |
| 2016 |
Effects of para–toluenesulfonamide intratumoral injection on non-small cell lung carcinoma with severe central airway obstruction: A multi-center, non-randomized, single-arm, open-label trial
|
Lung Cancer. 2016 Aug;98:43-50. |
| 2015 |
Para-toluenesulfonamide induces tongue squamous cell carcinoma cell death through disturbing lysosomal stability
|
Anticancer Drugs . 2015 Nov;26(10):1026-33 |
| 2013 |
Antitumor effect of para-toluenesulfonamide against lung cancer xenograft in a mouse model
|
J Thorac Dis 2013;5(4):472-483. |
| 2012 |
Puncture injection of para-toluenesulfonamide combined with chemoembolization for advanced hepatocellular carcinoma
|
World J Gastroenterol. 2012 Dec 14;18(46):6861-4. |
| 2006 |
Metabolism and effect of para-toluene-sulfonamide on rat liver microsomal cytochrome P450 from in vivo and in vitro studies
|
Acta Pharmacol Sin. 2006 May;27(5):635-40. |
| 2006 |
An evaluation of para toluene-sulfonamide metabolism and effect with regard to CYP isoforms, P-glycoprotein, and drug interactions
|
Pharmazie. 2006 Oct;61(10):869-73. |
